End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
296,000 KRW | +0.68% | +4.41% | -16.03% |
May. 16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.03% | 2.72B | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- A128940 Stock
- News Hanmi Pharm. Co., Ltd.
- Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8%